LONDON – The first disclosure on June 30 of payments to health care professionals – intended to bolster pharma's claim to effective self-regulation – came just a week after one of the most egregious case of noncompliance with industry codes concluded and Astellas UK was booted out of the Association of the British Pharmaceutical Industry (ABPI) for an unprecedented 12 months.